Risk factors for medication-induced diabetes and type 2 diabetes

J Pediatr. 2011 Aug;159(2):291-6. doi: 10.1016/j.jpeds.2011.01.017. Epub 2011 Feb 24.

Abstract

Objective: To compare the prevalence of risk factors in children aged <18 years diagnosed with medication-induced diabetes mellitus versus those diagnosed with type 2 diabetes.

Study design: This retrospective observational study used data from a Canadian prospective surveillance study in which clinical features of new cases of type 2 diabetes (n = 225) and medication-induced diabetes (n = 58) were reported over a 2-year period. The presence of risk factors for type 2 diabetes (eg, obesity, family history of type 2 diabetes, ethnicity, acanthosis nigricans, hypertension, polycystic ovarian syndrome) was compared in the 2 groups using descriptive statistics and logistic regression.

Results: Compared with the children with type 2 diabetes, the children with medication-induced diabetes were more likely to be Caucasian (P < .0001) and less likely to be obese (P < .0001), to have a positive family history of type 2 diabetes (P = .0001), to have acanthosis nigricans (P < .0001) on clinical examination, and to have an obesity-related comorbidity, such as polycystic ovarian syndrome (P = .04), dyslipidemia (P = .02), hypertension (P = .04), or an elevated alanine aminotransferase level (P = .05).

Conclusions: Evaluating for the typical risk factors for type 2 diabetes is not sufficient to identify all children at risk for developing medication-induced diabetes. Further studies are needed to help inform guidelines on screening for and prevention of medication-induced diabetes in children.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acanthosis Nigricans / drug therapy
  • Acanthosis Nigricans / epidemiology
  • Adolescent
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Canada / epidemiology
  • Child
  • Comorbidity
  • Diabetes Mellitus, Type 2 / chemically induced
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Dyslipidemias / drug therapy
  • Dyslipidemias / epidemiology
  • Female
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / therapeutic use
  • Humans
  • Hypertension / drug therapy
  • Hypertension / epidemiology
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Male
  • Obesity / drug therapy
  • Obesity / epidemiology
  • Population Surveillance
  • Retrospective Studies
  • Risk Assessment / methods*
  • Risk Factors

Substances

  • Antipsychotic Agents
  • Glucocorticoids
  • Immunosuppressive Agents